Daily Management Review

AstraZeneca & Ironwood In An Agreement On Zurampic Right


04/28/2016


The two pharmacists have arrived at an agreement whereby, they will support each other in developing gout treatment.



AstraZeneca has entered in a “licensing agreement” with the “Ironwood Pharmaceuticals” on the issue of “exclusive US rights to Zurampic”. The latter is used for treating “hyperuricemia” which results in “uncontrolled gout” problem.
 
The exclusive U.S. rights on Zurampic will be acquires by Ironwood for using the same in a “fixed-dose combination” which will involve “lesinurad and allopurinol”.
 
Moreover, AstraZeneca informed that it has plans of submitting the combination of the fixed dose to regulatory authorities for reviewing in the latter half of the year 2016, while Ironwood will make a payment to AstraZeneca for sales and other “milestone” related issues. The amount that will be paid by Ironwood to AstraZeneca is “$265m” in addition to “single-digit royalties on product sales”.
 
On the other hand, AstraZeneca will be manufacturing Zurampic and supply the same to Ironwood besides supporting some of Ironwood’s services. Furthermore, AstraZeneca will also be undertaking the “FDA post-approval commitment” on behalf of Ironwood.
 
 
References:
http://www.digitallook.com/







Science & Technology

Amazon’s Ring gets in a privacy scandal

Facebook Is Creating A Stablecoin For Its WhatsApp Users

IBM offers to use the first quantum computer

Passport Numbers Of 5 Million Customers Hacked: Concedes Marriott

China Lifts Approval Freeze On New Video Games Launch

Concentrated Solar Plant System To Dispatch Electricity To The Grid On Demand

Unique Underground Transportation Tunnel Revealed By Elon Musk

Toyota is trying to revive demand for Prius

Deloitte: Smart speakers will show record sales in 2019

China takes the lead in quantum cryptography

World Politics

World & Politics

Macedonia ignites political crisis in Greece

Brazil turns right

Merkel’s Pledge Of A United Germany in 2019

Murder Suspects Of Jamal Khashoggi Put On Trial By Saudi Arabia

Japan is trying to save its population with robots and migrants

Germany closes the last coal mine

US launches investigation against Airbus

European regions with the most polluted air